Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy: a Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Immune globulin (Primary)
- Indications Peripheral neuropathies
- Focus Therapeutic Use
- Acronyms IVIg-SFN
- 09 Jan 2018 Planned End Date changed from 1 May 2017 to 1 Sep 2018.
- 09 Jan 2018 Planned primary completion date changed from 1 May 2017 to 1 Sep 2018.
- 12 Jul 2016 Status changed from not yet recruiting to recruiting.